The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
Memory loss and difficulties with thinking associated with Alzheimer\'s disease may be due to chronic release of a brain chemical called glutamate. Glutamate helps transmit messages between nerve cells through interaction with a certain type of receptor (N-methyl-D-aspartate, NMDA) on the cell. Neramexane is a new drug that blocks the effects of excessive glutamate at the receptor (NMDA receptor antagonist).
Epistemonikos ID: 8a88c686c500e83af6adba9e7c7e9cd43dbf96ab
First added on: May 04, 2024